Skip to content

Effects of a pomegranate peel oral products on the prevention of oral mucositis induced by radiation therapy in head and neck cancer patients

Efficacy of an oral topical pomegranate peel (Punica granatum) product in prevention of acute radiation-induced oral mucositis in patients with head and neck cancer: A pilot study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240607062030N1
Enrollment
20
Registered
2025-04-24
Start date
2025-05-05
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation-induced oral mucositis. Oral mucositis (ulcerative) due to radiation

Interventions

Intervention 1: Invention group: The oral spray containing pomegranate peel extract will be used every four hours, six puffs each time, starting one day before the initiation of radiotherapy and conti

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Diagnosed with head and neck cancer based on pathology Candidate for head and neck radiotherapy The presence of at least two examined areas for mucositis (based on the mucositis assessment criteria) within the radiotherapy field Age between 18 and 75 years

Exclusion criteria

Exclusion criteria: History of allergy to pomegranate Presence of recurrent or infectious oral lesions Presence of dental diseases Liver and kidney diseases. Use of alcohol or medications affecting the salivary glands, such as antidepressants and opioids. Diagnosis of diabetes Diseases causing dehydration, such as chronic diarrhea History of connective tissue diseases such as Sjögren's syndrome, rheumatoid arthritis, and lupus.

Design outcomes

Primary

MeasureTime frame
Mucositis. Timepoint: Before intervention and the first to fifth weeks of radiotherapy and two weeks thereafter. Method of measurement: Clinical examination of seven areas of the oral cavity, questioning the patient using the VAS (Visual Analogue Scale).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza sayari

Islamic Azad University

rezasayari06@gmail.com+98 21 2264 0052

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026